Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 10, 2009, Pages 1149-1160

  Shay, Kate Petersen ^a   Moreau, Régis F ^a   Smith, Eric J ^a,b   Smith, Anthony R ^a   Hagen, Tory M ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Aging; Alpha lipoic acid; Antioxidant; Diabetes; Dietary supplement; Glutathione

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; BIODYNORAL; DIHYDROLIPOATE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE B; GLUCOSE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; IRBESARTAN; PHOSPHATASE; PHOSPHOTRANSFERASE; PLACEBO; THIOCTIC ACID; TIOBEC; TIOCRONAL; TIOCTIL; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

AGING; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; DETOXIFICATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; DRUG STRUCTURE; DRUG TISSUE LEVEL; DRUG UPTAKE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN METABOLISM; INSULIN RESISTANCE; KINESIOTHERAPY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RACEMIC MIXTURE; REVIEW; SIGNAL TRANSDUCTION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VASCULAR DISEASE; VITAMIN METABOLISM;

ANIMALS; DIABETIC NEUROPATHIES; DIETARY SUPPLEMENTS; HUMANS; HYPERTENSION; INFLAMMATION; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; THIOCTIC ACID; VASCULAR DISEASES;

ANIMALIA;

EID: 69949104384     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.07.026     Document Type: Review

References (151)

1. Smith A.R., Shenvi S.V., Widlansky M., Suh J.H., and Hagen T.M. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr. Med. Chem. 11 (2004) 1135-1146
2. Scott B.C., Aruoma O.I., Evans P.J., O'Neill C., Van der Vliet A., Cross C.E., Tritschler H., and Halliwell B. Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radic. Res. 20 (1994) 119-133
3. Devasagayam T.P., Subramanian M., Pradhan D.S., and Sies H. Prevention of singlet oxygen-induced DNA damage by lipoate. Chem. Biol. Interact. 86 (1993) 79-92
4. Liu J., Head E., Gharib A.M., Yuan W., Ingersoll R.T., Hagen T.M., Cotman C.W., and Ames B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-l-carnitine and/or R-alpha-lipoic acid. Proc. Natl. Acad. Sci. USA 99 (2002) 2356-2361
5. Suh J.H., Shenvi S.V., Dixon B.M., Liu H., Jaiswal A.K., Liu R.M., and Hagen T.M. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc. Natl. Acad. Sci. USA 101 (2004) 3381-3386
6. Lodge J.K., Traber M.G., and Packer L. Thiol chelation of Cu2+ by dihydrolipoic acid prevents human low density lipoprotein peroxidation. Free Radic. Biol. Med. 25 (1998) 287-297
7. Anuradha B., and Varalakshmi P. Protective role of DL-alpha-lipoic acid against mercury-induced neural lipid peroxidation. Pharmacol. Res. 39 (1999) 67-80
8. Han D., Sen C.K., Roy S., Kobayashi M.S., Tritschler H.J., and Packer L. Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants. Am. J. Physiol. 273 (1997) R1771-R1778
9. Reed L. Multienzyme complexes. Acc. Chem. Res. 7 (1974) 40-46
10. Vanden Boom T.J., Reed K.E., and Cronan Jr. J.E. Lipoic acid metabolism in Escherichia coli: isolation of null mutants defective in lipoic acid biosynthesis, molecular cloning and characterization of the E. coli lip locus, and identification of the lipoylated protein of the glycine cleavage system. J. Bacteriol. 173 (1991) 6411-6420
11. Akiba S., Matsugo S., Packer L., and Konishi T. Assay of protein-bound lipoic acid in tissues by a new enzymatic method. Anal. Biochem. 258 (1998) 299-304
12. Packer L., Kraemer K., and Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17 (2001) 888-895
13. Wollin S.D., and Jones P.J. Alpha-lipoic acid and cardiovascular disease. J. Nutr. 133 (2003) 3327-3330
14. Takaishi N., Yoshida K., Satsu H., and Shimizu M. Transepithelial transport of alpha-lipoic acid across human intestinal Caco-2 cell monolayers. J. Agric. Food Chem. 55 (2007) 5253-5259
15. Balamurugan K., Vaziri N.D., and Said H.M. Biotin uptake by human proximal tubular epithelial cells: cellular and molecular aspects. Am. J. Physiol., Renal Physiol. 288 (2005) F823-F831
16. Prasad P.D., Wang H., Kekuda R., Fujita T., Fei Y.J., Devoe L.D., Leibach F.H., and Ganapathy V. Cloning and functional expression of a cDNA encoding a mammalian sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin, and lipoate. J. Biol. Chem. 273 (1998) 7501-7506
17. Teichert J., Kern J., Tritschler H.J., Ulrich H., and Preiss R. Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. Int. J. Clin. Pharmacol. Ther. 36 (1998) 625-628
18. Carlson D.A., Smith A.R., Fischer S.J., Young K.L., and Packer L. The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects. Altern. Med. Rev. 12 (2007) 343-351
19. Breithaupt-Grogler K., Niebch G., Schneider E., Erb K., Hermann R., Blume H.H., Schug B.S., and Belz G.G. Dose-proportionality of oral thioctic acid-coincidence of assessments via pooled plasma and individual data. Eur. J. Pharm. Sci. 8 (1999) 57-65
20. Mignini F., Streccioni V., Tomassoni D., Traini E., and Amenta F. Comparative crossover, randomized, open-label bioequivalence study on the bioequivalence of two formulations of thioctic acid in healthy volunteers. Clin. Exp. Hypertens. 29 (2007) 575-586
21. Bernkop-Schnurch A., Reich-Rohrwig E., Marschutz M., Schuhbauer H., and Kratzel M. Development of a sustained release dosage form for alpha-lipoic acid. II. Evaluation in human volunteers. Drug Dev. Ind. Pharm. 30 (2004) 35-42
22. Amenta F., Traini E., Tomassoni D., and Mignini F. Pharmacokinetics of different formulations of tioctic (alpha-lipoic) acid in healthy volunteers. Clin. Exp. Hypertens. 30 (2008) 767-775
23. Teichert J., Tuemmers T., Achenbach H., Preiss C., Hermann R., Ruus P., and Preiss R. Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease. J. Clin. Pharmacol. 45 (2005) 313-328
24. Teichert J., Hermann R., Ruus P., and Preiss R. Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers. J. Clin. Pharmacol. 43 (2003) 1257-1267
25. Harrison E.H., and McCormick D.B. The metabolism of dl-(1, 6-14C)lipoic acid in the rat. Arch. Biochem. Biophys. 160 (1974) 514-522
26. Panigrahi M., Sadguna Y., Shivakumar B.R., Kolluri S.V., Roy S., Packer L., and Ravindranath V. alpha-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats. Brain Res. 717 (1996) 184-188
27. Arivazhagan P., Shila S., Kumaran S., and Panneerselvam C. Effect of DL-alpha-lipoic acid on the status of lipid peroxidation and antioxidant enzymes in various brain regions of aged rats. Exp. Gerontol. 37 (2002) 803-811
28. Chng H.T., New L.S., Neo A.H., Goh C.W., Browne E.R., and Chan E.C. Distribution study of orally administered lipoic acid in rat brain tissues. Brain Res. 1251 (2009) 80-86
29. Schupke H., Hempel R., Peter G., Hermann R., Wessel K., Engel J., and Kronbach T. New metabolic pathways of alpha-lipoic acid. Drug Metab. Dispos. 29 (2001) 855-862
30. Jones W., Li X., Qu Z.C., Perriott L., Whitesell R.R., and May J.M. Uptake, recycling, and antioxidant actions of alpha-lipoic acid in endothelial cells. Free Radic. Biol. Med. 33 (2002) 83-93
31. Farr S.A., Poon H.F., Dogrukol-Ak D., Drake J., Banks W.A., Eyerman E., Butterfield D.A., and Morley J.E. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J. Neurochem. 84 (2003) 1173-1183
32. Packer L., Witt E.H., and Tritschler H.J. alpha-Lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 19 (1995) 227-250
33. Biewenga G.P., Haenen G.R., and Bast A. The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 29 (1997) 315-331
34. Hill A.S., Werner J.A., Rogers Q.R., O'Neill S.L., and Christopher M.M. Lipoic acid is 10 times more toxic in cats than reported in humans, dogs or rats. J. Anim. Physiol. Anim. Nutr. (Berl.) 88 (2004) 150-156
35. Cremer D.R., Rabeler R., Roberts A., and Lynch B. Safety evaluation of alpha-lipoic acid (ALA). Regul. Toxicol. Pharmacol. 46 (2006) 29-41
36. Cremer D.R., Rabeler R., Roberts A., and Lynch B. Long-term safety of alpha-lipoic acid (ALA) consumption: a 2-year study. Regul. Toxicol. Pharmacol. 46 (2006) 193-201
37. Ziegler D., Hanefeld M., Ruhnau K.J., Meissner H.P., Lobisch M., Schutte K., and Gries F.A. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN study). Diabetologia 38 (1995) 1425-1433
38. Reljanovic M., Reichel G., Rett K., Lobisch M., Schuette K., Moller W., Tritschler H.J., and Mehnert H. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic. Res. 31 (1999) 171-179
39. Ziegler D., Hanefeld M., Ruhnau K.J., Hasche H., Lobisch M., Schutte K., Kerum G., and Malessa R. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 22 (1999) 1296-1301
40. Jacob S., Ruus P., Hermann R., Tritschler H.J., Maerker E., Renn W., Augustin H.J., Dietze G.J., and Rett K. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic. Biol. Med. 27 (1999) 309-314
41. Ruhnau K.J., Meissner H.P., Finn J.R., Reljanovic M., Lobisch M., Schutte K., Nehrdich D., Tritschler H.J., Mehnert H., and Ziegler D. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet. Med. 16 (1999) 1040-1043
42. Ametov A.S., Barinov A., Dyck P.J., Hermann R., Kozlova N., Litchy W.J., Low P.A., Nehrdich D., Novosadova M., O'Brien P.C., Reljanovic M., Samigullin R., Schuette K., Strokov I., Tritschler H.J., Wessel K., Yakhno N., and Ziegler D. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 26 (2003) 770-776
43. Ziegler D., Ametov A., Barinov A., Dyck P.J., Gurieva I., Low P.A., Munzel U., Yakhno N., Raz I., Novosadova M., Maus J., and Samigullin R. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 29 (2006) 2365-2370
44. Ziegler D., Schatz H., Conrad F., Gries F.A., Ulrich H., and Reichel G. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 20 (1997) 369-373
45. Borcea V., Nourooz-Zadeh J., Wolff S.P., Klevesath M., Hofmann M., Urich H., Wahl P., Ziegler R., Tritschler H., Halliwell B., and Nawroth P.P. alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic. Biol. Med. 26 (1999) 1495-1500
46. Yadav V., Marracci G., Lovera J., Woodward W., Bogardus K., Marquardt W., Shinto L., Morris C., and Bourdette D. Lipoic acid in multiple sclerosis: a pilot study. Mult. Scler. 11 (2005) 159-165
47. Sola S., Mir M.Q., Cheema F.A., Khan-Merchant N., Menon R.G., Parthasarathy S., and Khan B.V. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation 111 (2005) 343-348
48. Cakatay U., and Kayali R. Plasma protein oxidation in aging rats after alpha-lipoic acid administration. Biogerontology 6 (2005) 87-93
49. Cakatay U., Kayali R., Sivas A., and Tekeli F. Prooxidant activities of alpha-lipoic acid on oxidative protein damage in the aging rat heart muscle. Arch. Gerontol. Geriatr. 40 (2005) 231-240
50. Kayali R., Cakatay U., Akcay T., and Altug T. Effect of alpha-lipoic acid supplementation on markers of protein oxidation in post-mitotic tissues of ageing rat. Cell Biochem. Funct. 24 (2006) 79-85
51. Cakatay U., Kayali R., Kiziler A.R., and Aydemir B. Postmitotic tissue selenium and manganese levels in alpha-lipoic acid-supplemented aged rats. Chem. Biol. Interact. 171 (2008) 306-311
52. Searls R.L., and Sanadi D.R. alpha-Ketoglutaric dehydrogenase. 8. Isolation and some properties of a flavoprotein component. J. Biol. Chem. 235 (1960) 2485-2491
53. Trujillo M., and Radi R. Peroxynitrite reaction with the reduced and the oxidized forms of lipoic acid: new insights into the reaction of peroxynitrite with thiols. Arch. Biochem. Biophys. 397 (2002) 91-98
54. Vriesman M.F., Haenen G.R., Westerveld G.J., Paquay J.B., Voss H.P., and Bast A. A method for measuring nitric oxide radical scavenging activity. Scavenging properties of sulfur-containing compounds. Pharm. World Sci. 19 (1997) 283-286
55. Suzuki Y.J., Tsuchiya M., and Packer L. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic. Res. Commun. 15 (1991) 255-263
56. Suzuki Y.J., Tsuchiya M., and Packer L. Antioxidant activities of dihydrolipoic acid and its structural homologues. Free Radic. Res. Commun. 18 (1993) 115-122
57. Kaiser S., di Mascio P., and Sies H. Lipoat und Singulettsauerstoff. In: Borbe H.O., and Ulrich H. (Eds). Thioctseure (1989), pmi Verlag GmbH, Frankfurt 69-76
58. Devasagayam T.P., Di Mascio P., Kaiser S., and Sies H. Singlet oxygen induced single-strand breaks in plasmid pBR322 DNA: the enhancing effect of thiols. Biochim. Biophys. Acta 1088 (1991) 409-412
59. Kagan V.E., Shvedova A., Serbinova E., Khan S., Swanson C., Powell R., and Packer L. Dihydrolipoic acid-a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem. Pharmacol. 44 (1992) 1637-1649
60. Haenen G.R., and Bast A. Scavenging of hypochlorous acid by lipoic acid. Biochem. Pharmacol. 42 (1991) 2244-2246
61. Yan L.J., Traber M.G., Kobuchi H., Matsugo S., Tritschler H.J., and Packer L. Efficacy of hypochlorous acid scavengers in the prevention of protein carbonyl formation. Arch. Biochem. Biophys. 327 (1996) 330-334
62. Bast A., and Haenen G.R. Lipoic acid: a multifunctional antioxidant. Biofactors 17 (2003) 207-213
63. Ou P., Tritschler H.J., and Wolff S.P. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant?. Biochem. Pharmacol. 50 (1995) 123-126
64. Suh J.H., Moreau R., Heath S.H., and Hagen T.M. Dietary supplementation with (R)-alpha-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex. Redox Rep. 10 (2005) 52-60
65. Bush A.I. Metal complexing agents as therapies for Alzheimer's disease. Neurobiol. Aging 23 (2002) 1031-1038
66. Goralska M., Dackor R., Holley B., and McGahan M.C. Alpha lipoic acid changes iron uptake and storage in lens epithelial cells. Exp. Eye Res. 76 (2003) 241-248
67. Lykkesfeldt J., Hagen T.M., Vinarsky V., and Ames B.N. Age-associated decline in ascorbic acid concentration, recycling, and biosynthesis in rat hepatocytes-reversal with (R)-alpha-lipoic acid supplementation. FASEB J. 12 (1998) 1183-1189
68. Michels A.J., Joisher N., and Hagen T.M. Age-related decline of sodium-dependent ascorbic acid transport in isolated rat hepatocytes. Arch. Biochem. Biophys. 410 (2003) 112-120
69. Suh J.H., Shigeno E.T., Morrow J.D., Cox B., Rocha A.E., Frei B., and Hagen T.M. Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. FASEB J. 15 (2001) 700-706
70. Xu D.P., and Wells W.W. alpha-Lipoic acid dependent regeneration of ascorbic acid from dehydroascorbic acid in rat liver mitochondria. J. Bioenerg. Biomembranes 28 (1996) 77-85
71. Bast A., and Haenen G.R. Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochim. Biophys. Acta 963 (1988) 558-561
72. Busse E., Zimmer G., Schopohl B., and Kornhuber B. Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung 42 (1992) 829-831
73. Han D., Handelman G., Marcocci L., Sen C.K., Roy S., Kobuchi H., Tritschler H.J., Flohe L., and Packer L. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. BioFactors 6 (1997) 321-338
74. Suh J.H., Wang H., Liu R.M., Liu J., and Hagen T.M. (R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis. Arch. Biochem. Biophys. 423 (2004) 126-135
75. Lee S.R., Kwon K.S., Kim S.R., and Rhee S.G. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273 (1998) 15366-15372
76. Kilic F., Handelman G.J., Traber K., Tsang K., Packer L., and Trevithick J.R. Modelling cortical cataractogenesis XX. In vitro effect of alpha-lipoic acid on glutathione concentrations in lens in model diabetic cataractogenesis. Biochem. Mol. Biol. Int. 46 (1998) 585-595
77. Wolz P., and Krieglstein J. Neuroprotective effects of alpha-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia. Neuropharmacology 35 (1996) 369-375
78. Biewenga G.P., Dorstijn M.A., Verhagen J.V., Haenen G.R., and Bast A. Reduction of lipoic acid by lipoamide dehydrogenase. Biochem. Pharmacol. 51 (1996) 233-238
79. Hagen T.M., Vinarsky V., Wehr C.M., and Ames B.N. (R)-alpha-lipoic acid reverses the age-associated increase in susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro and in vivo. Antioxid. Redox Signal. 2 (2000) 473-483
80. Moini H., Tirosh O., Park Y.C., Cho K.J., and Packer L. R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3 T3-L1 adipocytes. Arch. Biochem. Biophys. 397 (2002) 384-391
81. Dinkova-Kostova A.T., Holtzclaw W.D., Cole R.N., Itoh K., Wakabayashi N., Katoh Y., Yamamoto M., and Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. USA 99 (2002) 11908-11913
82. Zhang D.D., Lo S.C., Cross J.V., Templeton D.J., and Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24 (2004) 10941-10953
83. Kobayashi A., Kang M.I., Watai Y., Tong K.I., Shibata T., Uchida K., and Yamamoto M. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell. Biol. 26 (2006) 221-229
84. Eggler A.L., Liu G., Pezzuto J.M., van Breemen R.B., and Mesecar A.D. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc. Natl. Acad. Sci. USA 102 (2005) 10070-10075
85. Hong F., Sekhar K.R., Freeman M.L., and Liebler D.C. Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. J. Biol. Chem. 280 (2005) 31768-31775
86. Yamamoto T., Suzuki T., Kobayashi A., Wakabayashi J., Maher J., Motohashi H., and Yamamoto M. Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol. Cell. Biol. 28 (2008) 2758-2770
87. Rachakonda G., Xiong Y., Sekhar K.R., Stamer S.L., Liebler D.C., and Freeman M.L. Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3. Chem. Res. Toxicol. 21 (2008) 705-710
88. Huang H.C., Nguyen T., and Pickett C.B. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277 (2002) 42769-42774
89. Bloom D.A., and Jaiswal A.K. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem. 278 (2003) 44675-44682
90. Huang H.C., Nguyen T., and Pickett C.B. Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc. Natl. Acad. Sci. USA 97 (2000) 12475-12480
91. Sen C.K., Sashwati R., and Packer L. Fas mediated apoptosis of human Jurkat T-cells: intracellular events and potentiation by redox-active alpha-lipoic acid. Cell Death Differ. 6 (1999) 481-491
92. Suzuki Y.J., Shi S.S., Day R.M., and Blumberg J.B. Differential regulation of MAP kinase signaling by pro- and antioxidant biothiols. Ann. N.Y. Acad. Sci. 899 (2000) 159-167
93. Shi S.S., Day R.M., Halpner A.D., Blumberg J.B., and Suzuki Y.J. Homocysteine and alpha-lipoic acid regulate p44/42 MAP kinase phosphorylation in NIH/3 T3 cells. Antioxid. Redox Signal. 1 (1999) 123-128
94. Konrad D., Somwar R., Sweeney G., Yaworsky K., Hayashi M., Ramlal T., and Klip A. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 50 (2001) 1464-1471
95. Petersen Shay K., and Hagen T.M. Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by alpha-lipoic acid through PI3 kinase, PTEN, and PP2A. Biogerontology 10 (2009) 443-456
96. Zhang W.J., Wei H., Hagen T., and Frei B. Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc. Natl. Acad. Sci. USA 104 (2007) 4077-4082
97. Smith A.R., and Hagen T.M. Vascular endothelial dysfunction in aging: loss of Akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (R)-alpha-lipoic acid. Biochem. Soc. Trans. 31 (2003) 1447-1449
98. Saengsirisuwan V., Perez F.R., Sloniger J.A., Maier T., and Henriksen E.J. Interactions of exercise training and alpha-lipoic acid on insulin signaling in skeletal muscle of obese Zucker rats. Am. J. Physiol., Endocrinol. Metab. 287 (2004) E529-E536
99. Cho K.J., Moini H., Shon H.K., Chung A.S., and Packer L. Alpha-lipoic acid decreases thiol reactivity of the insulin receptor and protein tyrosine phosphatase 1B in 3T3-L1 adipocytes. Biochem. Pharmacol. 66 (2003) 849-858
100. Foley T.D., Petro L.A., Stredny C.M., and Coppa T.M. Oxidative inhibition of protein phosphatase 2A activity: role of catalytic subunit disulfides. Neurochem. Res. 32 (2007) 1957-1964
101. Boivin B., Zhang S., Arbiser J.L., Zhang Z.Y., and Tonks N.K. A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells. Proc. Natl. Acad. Sci. USA 105 (2008) 9959-9964
102. Ross S.H., Lindsay Y., Safrany S.T., Lorenzo O., Villa F., Toth R., Clague M.J., Downes C.P., and Leslie N.R. Differential redox regulation within the PTP superfamily. Cell. Signal. 19 (2007) 1521-1530
103. Lee S.R., Yang K.S., Kwon J., Lee C., Jeong W., and Rhee S.G. Reversible inactivation of the tumor suppressor PTEN by H2O2. J. Biol. Chem. 277 (2002) 20336-20342
104. Diesel B., Kulhanek-Heinze S., Holtje M., Brandt B., Holtje H.D., Vollmar A.M., and Kiemer A.K. Alpha-lipoic acid as a directly binding activator of the insulin receptor: protection from hepatocyte apoptosis. Biochemistry 46 (2007) 2146-2155
105. Jessen N., and Goodyear L.J. Contraction signaling to glucose transport in skeletal muscle. J. Appl. Physiol. 99 (2005) 330-337
106. Cartee G.D., and Wojtaszewski J.F. Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport. Appl. Physiol. Nutr. Metab. 32 (2007) 557-566
107. Kim M.S., Park J.Y., Namkoong C., Jang P.G., Ryu J.W., Song H.S., Yun J.Y., Namgoong I.S., Ha J., Park I.S., Lee I.K., Viollet B., Youn J.H., Lee H.K., and Lee K.U. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat. Med. 10 (2004) 727-733
108. Lee W.J., Lee I.K., Kim H.S., Kim Y.M., Koh E.H., Won J.C., Han S.M., Kim M.S., Jo I., Oh G.T., Park I.S., Youn J.H., Park S.W., Lee K.U., and Park J.Y. Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2488-2494
109. Lee W.J., Song K.H., Koh E.H., Won J.C., Kim H.S., Park H.S., Kim M.S., Kim S.W., Lee K.U., and Park J.Y. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem. Biophys. Res. Commun. 332 (2005) 885-891
110. Paz K., Hemi R., LeRoith D., Karasik A., Elhanany E., Kanety H., and Zick Y. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J. Biol. Chem. 272 (1997) 29911-29918
111. Jakobsen S.N., Hardie D.G., Morrice N., and Tornqvist H.E. 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J. Biol. Chem. 276 (2001) 46912-46916
112. Treebak J.T., Glund S., Deshmukh A., Klein D.K., Long Y.C., Jensen T.E., Jorgensen S.B., Viollet B., Andersson L., Neumann D., Wallimann T., Richter E.A., Chibalin A.V., Zierath J.R., and Wojtaszewski J.F. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 55 (2006) 2051-2058
113. Shen Q.W., Zhu M.J., Tong J., Ren J., and Du M. Ca2+/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by {alpha}-lipoic acid in C2C12 myotubes. Am. J. Physiol., Cell Physiol. 293 4 (2007) C1395-C1403
114. Tsakiridis T., McDowell H.E., Walker T., Downes C.P., Hundal H.S., Vranic M., and Klip A. Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells. Endocrinology 136 (1995) 4315-4322
115. Yaworsky K., Somwar R., Ramlal T., Tritschler H.J., and Klip A. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia 43 (2000) 294-303
116. Estrada D.E., Ewart H.S., Tsakiridis T., Volchuk A., Ramlal T., Tritschler H., and Klip A. Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes 45 (1996) 1798-1804
117. Henriksen E.J., Jacob S., Streeper R.S., Fogt D.L., Hokama J.Y., and Tritschler H.J. Stimulation by alpha-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats. Life Sci. 61 (1997) 805-812
118. Streeper R.S., Henriksen E.J., Jacob S., Hokama J.Y., Fogt D.L., and Tritschler H.J. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. Am. J. Physiol. 273 (1997) E185-E191
119. Hughes V.A., Fiatarone M.A., Fielding R.A., Kahn B.B., Ferrara C.M., Shepherd P., Fisher E.C., Wolfe R.R., Elahi D., and Evans W.J. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am. J. Physiol. 264 (1993) E855-E862
120. Jacob S., Streeper R.S., Fogt D.L., Hokama J.Y., Tritschler H.J., Dietze G.J., and Henriksen E.J. The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes 45 (1996) 1024-1029
121. Jacob S., Henriksen E.J., Schiemann A.L., Simon I., Clancy D.E., Tritschler H.J., Jung W.I., Augustin H.J., and Dietze G.J. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung 45 (1995) 872-874
122. Konrad T., Vicini P., Kusterer K., Hoflich A., Assadkhani A., Bohles H.J., Sewell A., Tritschler H.J., Cobelli C., and Usadel K.H. alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 22 (1999) 280-287
123. Ziegler D., Nowak H., Kempler P., Vargha P., and Low P.A. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 21 (2004) 114-121
124. Heitzer T., Finckh B., Albers S., Krohn K., Kohlschutter A., and Meinertz T. Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic. Biol. Med. 31 (2001) 53-61
125. Sena C.M., Nunes E., Louro T., Proenca T., Fernandes R., Boarder M.R., and Seica R.M. Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. Br. J. Pharmacol. 153 5 (2007) 894-906
126. Montagnani M., Ravichandran L.V., Chen H., Esposito D.L., and Quon M.J. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol. Endocrinol. 16 (2002) 1931-1942
127. Federici M., Menghini R., Mauriello A., Hribal M.L., Ferrelli F., Lauro D., Sbraccia P., Spagnoli L.G., Sesti G., and Lauro R. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 106 (2002) 466-472
128. Hagen T.M., Moreau R., Suh J.H., and Visioli F. Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-l-carnitine and/or lipoic acid. Ann. N.Y. Acad. Sci. 959 (2002) 491-507
129. Petersen Shay K., Moreau R.F., Smith E.J., and Hagen T.M. Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity. IUBMB Life 60 (2008) 362-367
130. Vasdev S., Gill V., Longerich L., Parai S., and Gadag V. Salt-induced hypertension in WKY rats: prevention by alpha-lipoic acid supplementation. Mol. Cell. Biochem. 254 (2003) 319-326
131. Vasdev S., Ford C.A., Parai S., Longerich L., and Gadag V. Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats. Nutr. Metab. Cardiovasc. Dis. 10 (2000) 339-346
132. Vasdev S., Ford C.A., Parai S., Longerich L., and Gadag V. Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J. Hypertens. 18 (2000) 567-573
133. Vasdev S., Gill V., Parai S., and Gadag V. Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats. Mol. Cell. Biochem. 275 (2005) 135-141
134. Louhelainen M., Merasto S., Finckenberg P., Lapatto R., Cheng Z.J., and Mervaala E.M. Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats. J. Hypertens. 24 (2006) 947-956
135. El Midaoui A., and de Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid. Hypertension 39 (2002) 303-307
136. Midaoui A.E., Elimadi A., Wu L., Haddad P.S., and de Champlain J. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. Am. J. Hypertens. 16 (2003) 173-179
137. Takaoka M., Kobayashi Y., Yuba M., Ohkita M., and Matsumura Y. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats. Eur. J. Pharmacol. 424 (2001) 121-129
138. McMackin C.J., Widlansky M.E., Hamburg N.M., Huang A.L., Weller S., Holbrook M., Gokce N., Hagen T.M., Keaney Jr. J.F., and Vita J.A. Effect of combined treatment with alpha-lipoic acid and acetyl-l-carnitine on vascular function and blood pressure in patients with coronary artery disease. J. Clin. Hypertens. (Greenwich) 9 (2007) 249-255
139. Kunt T., Forst T., Wilhelm A., Tritschler H., Pfuetzner A., Harzer O., Engelbach M., Zschaebitz A., Stofft E., and Beyer J. Alpha-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products. Clin. Sci. (Lond.) 96 (1999) 75-82
140. Kim H.S., Kim H.J., Park K.G., Kim Y.N., Kwon T.K., Park J.Y., Lee K.U., Kim J.G., and Lee I.K. Alpha-lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-kappaB transcriptional activity. Exp. Mol. Med. 39 (2007) 106-113
141. Chaudhary P., Marracci G.H., and Bourdette D.N. Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 175 (2006) 87-96
142. Lee E.Y., Lee C.K., Lee K.U., Park J.Y., Cho K.J., Cho Y.S., Lee H.R., Moon S.H., Moon H.B., and Yoo B. Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice. Rheumatol. Int. 27 (2007) 225-233
143. Morini M., Roccatagliata L., Dell'Eva R., Pedemonte E., Furlan R., Minghelli S., Giunti D., Pfeffer U., Marchese M., Noonan D., Mancardi G., Albini A., and Uccelli A. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 148 (2004) 146-153
144. Marracci G.H., Marquardt W.E., Strehlow A., McKeon G.P., Gross J., Buck D.C., Kozell L.B., and Bourdette D.N. Lipoic acid downmodulates CD4 from human T lymphocytes by dissociation of p56(Lck). Biochem. Biophys. Res. Commun. 344 (2006) 963-971
145. Schillace R.V., Pisenti N., Pattamanuch N., Galligan S., Marracci G.H., Bourdette D.N., and Carr D.W. Lipoic acid stimulates cAMP production in T lymphocytes and NK cells. Biochem. Biophys. Res. Commun. 354 (2007) 259-264
146. Larghero P., Vene R., Minghelli S., Travaini G., Morini M., Ferrari N., Pfeffer U., Noonan D.M., Albini A., and Benelli R. Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression. Carcinogenesis 28 (2007) 1008-1020
147. Cho Y.S., Lee J., Lee T.H., Lee E.Y., Lee K.U., Park J.Y., and Moon H.B. alpha-Lipoic acid inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J. Allergy Clin. Immunol. 114 (2004) 429-435
148. Zhang W.J., and Frei B. Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J. 15 (2001) 2423-2432
149. Ikeda U., Ito T., and Shimada K. Interleukin-6 and acute coronary syndrome. Clin. Cardiol. 24 (2001) 701-704
150. Wang S.J., and Chen H.H. Presynaptic mechanisms underlying the alpha-lipoic acid facilitation of glutamate exocytosis in rat cerebral cortex nerve terminals. Neurochem. Int. 50 (2007) 51-60
151. Stoll S., Hartmann H., Cohen S.A., and Muller W.E. The potent free radical scavenger alpha-lipoic acid improves memory in aged mice: putative relationship to NMDA receptor deficits. Pharmacol. Biochem. Behav. 46 (1993) 799-805